johnson & johnson

Partnering for Disaster Preparedness in Chile

IBM and Johnson & Johnson Team up in Santiago to Strengthen Community Resilience
Article

The term “natural disaster” is a misnomer. Natural ecosystems often require disturbances such as fires and floods to remain healthy. They have an inherent resilience to the occasional battering. Crises created by destructive natural events might be more aptly referred to as “social disasters,” because of the toll of life and economic damage left in their wake. Framing such events as social disasters places them in a different light, shifting the burden on all sectors of society to proactively manage the threat.

Johnson & Johnson Among FORTUNE Magazine's 2019 'World's Most Admired Companies'

The company has been honored with a spot on the prestigious list for the 17th year in a row for its innovative spirit and commitment to social responsibility, among other respected attributes.
Article

The results are in, and Johnson & Johnson has been named to Fortune’s list of the World’s Most Admired Companies for the 17th year, ranking in the top 20. Johnson & Johnson also placed #1 in the Pharmaceutical category worldwide for the sixth consecutive year, making it the highest-ranked healthcare company to appear on the top companies list in 2019.

J&J Exec: Tuberculosis is a Global Emergency. It's Time to Start Treating it That Way

By Paul Stoffels
Summary: 
  • Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
     
  • Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
     
  • An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.
Article
  • Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
     
  • Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
     
  • An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.

Meet a Johnson & Johnson Researcher Poised to Crack the HIV Vaccine Code

In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who's hard at work on the holy grail of HIV research: a preventive treatment.
Article

By Sheila Weller

In 1992, as a young HIV/AIDS researcher in her native Netherlands, Hanneke Schuitemaker, Ph.D., now Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention B.V., was devoted to learning as much as she could about the disease—and saw her role as that of a researcher, rather than someone who closely interacted with people who were living with HIV.

But that quickly changed.

Johnson & Johnson Earns a Top Spot on the 2018 Access to Medicine Index

The company has secured a top ranking on the biannual report—which grades companies on their efforts to make medicine more accessible to those in low- and middle-income countries—for the sixth consecutive time.
Article

One billion. That's how many lives Johnson & Johnson is committed to impacting through its Health for Humanity 2020 Goals, which include a pledge to deliver innovative healthcare access to some of the world's most underserved communities and cutting-edge training programs for frontline healthcare workers.

Putting Kids Around the Globe First: Johnson & Johnson Announces a $10 Million Pledge to UNICEF

It's one of the company's largest commitments to date, and it aims to help support the crucial work being done by frontline health workers to help more children grow up healthy.
Article

If there's one universal truth about kids, it may be this: They want to grow up as quickly as possible. And for over 100 years, Johnson & Johnson has been working to help them grow up as healthy as possible, too.

Johnson & Johnson Consumer Inc. Makes a New Pledge to Help Tackle Plastic Waste

The company is joining forces with more than 240 other organizations to be part of the New Plastics Economy Global Commitment for the good of the globe.
Article

In 1947, decades before the concept of sustainability became popular, then Johnson & Johnson Chairman and CEO General Robert Wood Johnson wrote in his book, Or Forfeit Freedom: “We must use our resources wisely, avoiding waste of both raw materials and scrap, while we seek substitutes for things already in short supply.”

Johnson & Johnson Consumer Aligns To Big Goals In Environmental Sustainability, Signs New Plastics Economy Global Commitment

Company sets sights on 100% reusable, recyclable or compostable packaging by 2025
Press Release

NEW BRUNSWICK, N.J., Oct. 31, 2018 /3BL Media/ - Johnson & Johnson Consumer, Inc. today announced the company is joining an ambitious effort to move the world closer to a circular economy in which plastic never becomes waste. Together with the Ellen MacArthur Foundation, the UN Environment Programme, and many industry-leading companies, governments, and NGOs this commitment will strive to meet goals to tackle one of the most urgent environmental issues of our time: plastic waste and the necessity of consumer packaging reform.

Pages

Subscribe to johnson & johnson